Published November 15, 2021 | Version Accepted Version + Supplemental Material
Journal Article Open

Biocatalytic, Intermolecular C−H Bond Functionalization for the Synthesis of Enantioenriched Amides

  • 1. ROR icon California Institute of Technology
  • 2. ROR icon Binghamton University

Abstract

Directed evolution of heme proteins has opened access to new-to-nature enzymatic activity that can be harnessed to tackle synthetic challenges. Among these, reactions resulting from active site iron-nitrenoid intermediates present a powerful strategy to forge C−N bonds with high site- and stereoselectivity. Here we report a biocatalytic, intermolecular benzylic C−H amidation reaction operating at mild and scalable conditions. With hydroxamate esters as nitrene precursors, feedstock aromatic compounds can be converted to chiral amides with excellent enantioselectivity (up to >99 % ee) and high yields (up to 87 %). Kinetic and computational analysis of the enzymatic reaction reveals rate-determining nitrenoid formation followed by stepwise hydrogen atom transfer-mediated C−H functionalization.

Additional Information

© 2021 Wiley-VCH GmbH. Issue Online: 08 November 2021; Version of Record online: 13 October 2021; Accepted manuscript online: 17 September 2021; Manuscript revised: 16 September 2021; Manuscript received: 12 August 2021. This research was supported in part by the NIH National Institute of General Medical Sciences (R01GM125887), the ACS GCI Pharmaceutical Roundtable Research Grant (F.H.A., S.V.A.), and Binghamton University startup funds (J.S.H.). J.S.H. and M.S.C. acknowledge support from the XSEDE Science Gateways Program (CHE180061 and CHE210031), which is supported by NSF grant number ACI-1548562. We thank S. Brinkmann-Chen for helpful discussion and comments. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. The authors declare no conflict of interest.

Attached Files

Accepted Version - nihms-1741559.pdf

Supplemental Material - anie202110873-sup-0001-misc_information.pdf

Supplemental Material - anie202110873-sup-0001-si.xlsx

Files

anie202110873-sup-0001-misc_information.pdf

Files (5.5 MB)

Name Size
md5:918a3ade5b5732e3bed3757fe16c9bdb
4.2 MB Preview Download
md5:71654f50551015c587982c1f23d53362
84.3 kB Download
md5:2b818f093eb1d63ff5bc47bf55116cdd
1.3 MB Preview Download

Additional details

Identifiers

PMCID
PMC8578410
Eprint ID
111321
DOI
10.1002/anie.202110873
Resolver ID
CaltechAUTHORS:20211008-224620449

Related works

Describes
10.1002/anie.202110873 (DOI)

Funding

NIH
R01GM125887
American Chemical Society GCI Pharmaceutical Roundtable
Binghamton University
NSF
CHE-180061
NSF
CHE-210031
NSF
ACI-1548562

Dates

Created
2021-10-12
Created from EPrint's datestamp field
Updated
2023-07-07
Created from EPrint's last_modified field

Caltech Custom Metadata